Next Article in Journal
An HIV Vaccine for South-East Asia—Opportunities and Challenges
Previous Article in Journal
Isotype Diversification of IgG Antibodies to HIV Gag Proteins as a Therapeutic Vaccination Strategy for HIV Infection
Previous Article in Special Issue
A Multidisciplinary Research Agenda for Understanding Vaccine-Related Decisions
Article Menu

Export Article

Open AccessOpinion
Vaccines 2013, 1(3), 343-347;

Trust in Vaccines: Why It Takes More than Good Faith

Chief Medical Officer, GlaxoSmithKline Vaccines, Avenue Fleming, 1300 Wavre, Belgium
Received: 29 May 2013 / Revised: 21 June 2013 / Accepted: 10 July 2013 / Published: 12 August 2013
(This article belongs to the Special Issue Confidence in Vaccines)
Full-Text   |   PDF [218 KB, uploaded 12 August 2013]


This Vaccines issue on “Confidence in Vaccines” provides sound evidence through multiple perspectives of life-saving impacts when vaccination programs are effectively implemented in a population. Yet there remain challenges to achieving this impact, including scientific, medical, manufacturing, policy-related and logistical issues. Additionally, socio-cultural, religious and political agendas can come into play, taking public health hostage and sometimes allowing the circulation of myths regarding vaccination. All of these challenges play a role in public confidence in vaccines and vaccination. What we trust, we embrace. What we do not trust, we do not embrace. View Full-Text
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Begg, N. Trust in Vaccines: Why It Takes More than Good Faith. Vaccines 2013, 1, 343-347.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top